Middle East & Africa Cell and Gene Therapy Manufacturing Services Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Regional Analysis

6.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Revenue 2020-2030 (US$ Million)

6.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Forecast Analysis

7. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Analysis – by Type

7.1 Cell Therapy

7.1.1 Overview
7.1.2 Cell Therapy: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Gene Therapy

7.2.1 Overview
7.2.2 Gene Therapy: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Analysis – by Indication

8.1 Cancer

8.1.1 Overview
8.1.2 Cancer: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Orthopedics

8.2.1 Overview
8.2.2 Orthopedics: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Analysis – by Application

9.1 Clinical Manufacturing

9.1.1 Overview
9.1.2 Clinical Manufacturing: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Commercial Manufacturing

9.2.1 Overview
9.2.2 Commercial Manufacturing: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Analysis – by End User

10.1 Pharmaceutical and Biotechnology Companies

10.1.1 Overview
10.1.2 Pharmaceutical and Biotechnology Companies: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Contract Research Organization

10.2.1 Overview
10.2.2 Contract Research Organization: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Middle East and Africa Analysis

11.1 Overview

11.2 Middle East and Africa

11.2.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast Analysis – by Country
11.2.1.1 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.1.2 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.1.3 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.1.4 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.2 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.2.2 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.2.3 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.2.4 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.3 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.3.2 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.3.3 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.3.4 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

11.2.1.4 Rest of Middle East and Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Type
11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Indication
11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by Application
11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Lonza Group AG

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Merck KgaA

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Nikon Corp

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Takara Bio Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Thermo Fisher Scientific Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 WuXi AppTec Co Ltd

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Middle East & Africa Cell and Gene Therapy Manufacturing Services Market